Friday, October 26, 2012

• [video] The Next Big Thing in Biotech: Earningsat TheStreet (Fri, Oct 26)

Wednesday, October 24, 2012

• This Big Biotech Rejoices, but for How Long?at Motley Fool (Wed, Oct 24)

Monday, October 22, 2012

• Job Killers: A Rogues' Galleryat Forbes (Mon, Oct 22)

Saturday, October 20, 2012

• The Dangers of Chasing Performance in Biotechat Motley Fool (Sat, Oct 20)
• 3 Big Events for 1 Big Pharmaat Motley Fool (Sat, Oct 20)

Friday, October 19, 2012

• This Spinoff Just Got More Interestingat Motley Fool (Fri, Oct 19)
• Amgen and Other Healthcare Stocks Making Big Moves on October 19, 2012at Investopedia (Fri, Oct 19)
• Players In Hepatitis C Treatment Market Officially In Playat Seeking Alpha (Fri, Oct 19)

Wednesday, October 17, 2012

• Diving Into the Johnson & Johnson Earnings Reportat Motley Fool (Wed, Oct 17)
• 4 Biotechs Targeting Fibrosisat Seeking Alpha (Wed, Oct 17)
• Vertex Pharmaceuticals Stock Hold Recommendation Reiterated (VRTX)at TheStreet (Wed, Oct 17)

Tuesday, October 16, 2012

• A Hep C Hip Checkat Motley Fool (Tue, Oct 16)

Monday, October 15, 2012

• Abbott Labs rises on hepatitis C drug dataAP (Mon, Oct 15)
• Confounding Combo Dataat Motley Fool (Mon, Oct 15)
• Abbott Hep C Therapy Achieves Almost-Perfect Cure Rateat TheStreet (Mon, Oct 15)

Saturday, October 13, 2012

• Sirius XM Issued Higher Estimates and 4 Stock Analyses Sparking Chatterat Wall St. Cheat Sheet (Sat, Oct 13)

Friday, October 12, 2012

• 4 Headline Moving Health-Care Stocksat Motley Fool (Fri, Oct 12)
• Bonanza Creek Energy Target Raised and 4 Stock Analyses Trending Nowat Wall St. Cheat Sheet (Fri, Oct 12)
• Vertex Pharmaceuticals (VRTX): Today's Featured Drugs Laggardat TheStreet (Fri, Oct 12)
• Stock Price, Volume Down; Hain, Vertex Each Slide 5%at Investor's Business Daily (Fri, Oct 12)
• Vertex Pharmaceuticals and More Big Movers in Healthcare on October 12, 2012at Investopedia (Fri, Oct 12)
• Vertex Gets Uneasy On Mixed Clinical Trial Resultsat Seeking Alpha (Fri, Oct 12)
• Today's Top Health-Care Headlinesat Motley Fool (Fri, Oct 12)

Thursday, October 11, 2012

• Independent Expert Likes Vertex CF Dataat Forbes (Thu, Oct 11)
• Vertex Cystic Fibrosis Combo Therapy Passes Key Confidence Testat TheStreet (Thu, Oct 11)

Add VRTX News to My Yahoo!